Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.

Aged Aged, 80 and over Cognitive Dysfunction / epidemiology Cohort Studies Dementia / epidemiology Diagnostic Self Evaluation Disease Progression Female Humans Incidence Male Middle Aged Risk Factors Self Concept
Alzheimer's disease Dementia Lewy bodies Dementia incidence Frontotemporal dementia Preclinical Alzheimer's disease Subjective cognitive decline Vascular dementia

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
03 2019
Historique:
received: 04 01 2018
revised: 03 09 2018
accepted: 03 10 2018
pubmed: 18 12 2018
medline: 6 5 2020
entrez: 18 12 2018
Statut: ppublish

Résumé

In this multicenter study on subjective cognitive decline (SCD) in community-based and memory clinic settings, we assessed the (1) incidence of Alzheimer's disease (AD) and non-AD dementia and (2) determinants of progression to dementia. Eleven cohorts provided 2978 participants with SCD and 1391 controls. We estimated dementia incidence and identified risk factors using Cox proportional hazards models. In SCD, incidence of dementia was 17.7 (95% Poisson confidence interval 15.2-20.3)/1000 person-years (AD: 11.5 [9.6-13.7], non-AD: 6.1 [4.7-7.7]), compared with 14.2 (11.3-17.6) in controls (AD: 10.1 [7.7-13.0], non-AD: 4.1 [2.6-6.0]). The risk of dementia was strongly increased in SCD in a memory clinic setting but less so in a community-based setting. In addition, higher age (hazard ratio 1.1 [95% confidence interval 1.1-1.1]), lower Mini-Mental State Examination (0.7 [0.66-0.8]), and apolipoprotein E ε4 (1.8 [1.3-2.5]) increased the risk of dementia. SCD can precede both AD and non-AD dementia. Despite their younger age, individuals with SCD in a memory clinic setting have a higher risk of dementia than those in community-based cohorts.

Identifiants

DOI: 10.1016/j.jalz.2018.10.003 PMID: 30555032 PMC: PMC6465066
pubmed: 30555032
pii: S1552-5260(18)33563-5
doi: 10.1016/j.jalz.2018.10.003
pmc: PMC6465066
mid: NIHMS1021068
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

465-476

Subventions

Organisme : NIA NIH HHS
ID : R01 AG019771
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010133
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG008051
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG003051
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG049050
Pays : United States

Investigateurs

Mercè Boada (M)
Peter Paul de Deyn (PP)
Roy Jones (R)
Giovanni Frisoni (G)
Luiza Spiru (L)
Flavio Nobili (F)
Yvonne Freund-Levi (Y)
Hilkka Soininen (H)
Frans Verhey (F)
Åsa K Wallin (ÅK)
Jacques Touchon (J)
Marcel Olde Rikkert (MO)
Anne-Sophie Rigaud (AS)
Roger Bullock (R)
Magda Tsolaki (M)
Bruno Vellas (B)
Gordon Wilcock (G)
Harald Hampel (H)
Lutz Froelich (L)
Hovagim Bakardjian (H)
Habib Benali (H)
Hugo Bertin (H)
Joel Bonheur (J)
Laurie Boukadida (L)
Nadia Boukerrou (N)
Enrica Cavedo (E)
Patrizia Chiesa (P)
Olivier Colliot (O)
Bruno Dubois (B)
Marion Dubois (M)
Stéphane Epelbaum (S)
Geoffroy Gagliardi (G)
Remy Genthon (R)
Marie-Odile Habert (MO)
Harald Hampel (H)
Marion Houot (M)
Aurélie Kas (A)
Foudil Lamari (F)
Marcel Levy (M)
Simone Lista (S)
Christiane Metzinger (C)
Fanny Mochel (F)
Francis Nyasse (F)
Catherine Poisson (C)
Marie-Claude Potier (MC)
Marie Revillon (M)
Antonio Santos (A)
Katia Santos Andrade (KS)
Marine Sole (M)
Mohmed Surtee (M)
Michel Thiebaud de Schotten (M)
Andrea Vergallo (A)
Nadjia Younsi (N)

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Neurology. 1996 Jan;46(1):121-5
pubmed: 8559359
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Alzheimers Res Ther. 2018 Aug 7;10(1):76
pubmed: 30081935
Neurology. 2005 Dec 27;65(12):1863-72
pubmed: 16237129
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Lancet. 2016 Jul 30;388(10043):505-17
pubmed: 26921134
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S109-14
pubmed: 26402081
Dement Geriatr Cogn Disord. 2009;27(5):404-17
pubmed: 19339779
Neurology. 2000;54(11 Suppl 5):S10-5
pubmed: 10854355
Int Psychogeriatr. 2010 Dec;22(8):1248-64
pubmed: 20637138
J Alzheimers Dis. 2016;51(4):1145-55
pubmed: 26923008
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):310-5
pubmed: 23314064
Lancet. 2015 Oct 24;386(10004):1698-706
pubmed: 26595643
Lancet Neurol. 2018 Apr;17(4):335-346
pubmed: 29500152
Alzheimers Dement. 2014 Nov;10(6):844-52
pubmed: 24798886
J Alzheimers Dis. 2018;62(3):1091-1111
pubmed: 29562540
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Alzheimers Dement. 2017 May;13(5):550-560
pubmed: 27693187
Alzheimers Dement. 2018 Jun;14(6):734-742
pubmed: 29352855
Br J Psychiatry. 2001 Sep;179:250-4
pubmed: 11532803
Br J Psychiatry. 2002 Mar;180:270-6
pubmed: 11872521
Alzheimers Res Ther. 2016 Jul 30;8(1):23
pubmed: 27473681
Neurology. 2010 Oct 5;75(14):1249-55
pubmed: 20810999
Lancet Neurol. 2013 Feb;12(2):207-16
pubmed: 23332364
Acta Psychiatr Scand. 2014 Dec;130(6):439-51
pubmed: 25219393
Alzheimers Dement (Amst). 2015 May 02;1(2):194-205
pubmed: 27239504
Science. 1993 Aug 13;261(5123):921-3
pubmed: 8346443
Lancet. 2015 Oct 24;386(10004):1672-82
pubmed: 26595641
JAMA Neurol. 2017 Dec 1;74(12):1481-1491
pubmed: 29049480
Nat Rev Neurol. 2013 Feb;9(2):106-18
pubmed: 23296339
Alzheimers Dement. 2015 Dec;11(12):1417-1429
pubmed: 25960448
Alzheimers Dement. 2010 Jan;6(1):11-24
pubmed: 20129317
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S125-40
pubmed: 26402078
BJPsych Bull. 2015 Feb;39(1):6-11
pubmed: 26191416
Alzheimers Dement. 2013 Sep;9(5):481-7
pubmed: 23232269
Am J Geriatr Psychiatry. 2009 May;17(5):368-75
pubmed: 19390294
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S63-86
pubmed: 26402085
J Alzheimers Dis. 2017;57(2):625-632
pubmed: 28269773
Am J Geriatr Psychiatry. 2014 Dec;22(12):1642-51
pubmed: 24698445
Alzheimers Dement. 2018 Sep;14(9):1126-1136
pubmed: 29792873
Am J Psychiatry. 1999 Apr;156(4):531-7
pubmed: 10200730
J Alzheimers Dis. 2014;41(1):313-27
pubmed: 24614907
Alzheimers Dement. 2017 Mar;13(3):296-311
pubmed: 27825022
Neuroepidemiology. 2008;30(4):254-65
pubmed: 18515975
Int Psychogeriatr. 2009 Aug;21(4):672-87
pubmed: 19470201
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S99-S107
pubmed: 26402087
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Neuroepidemiology. 2014;43(1):9-14
pubmed: 24993387
Neurology. 2000;54(11 Suppl 5):S4-9
pubmed: 10854354
Arch Gen Psychiatry. 2010 Apr;67(4):414-22
pubmed: 20368517

Auteurs

Rosalinde E R Slot (RER)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Sietske A M Sikkes (SAM)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands; Department of Epidemiology and Biostatistics, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Johannes Berkhof (J)

Department of Epidemiology and Biostatistics, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Henry Brodaty (H)

Center for Healthy Brain Ageing and Dementia Centre for Research Collaboration, University of New South Wales, Sydney, Australia.

Rachel Buckley (R)

University of Melbourne, Melbourne, Australia; The Florey Institutes of Neurosciences and Mental Health, Melbourne, Australia; Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.

Enrica Cavedo (E)

AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.

Efthimios Dardiotis (E)

Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece.

Francoise Guillo-Benarous (F)

New York University Alzheimer's Disease Center, NYU Langone Medical Center, New York, NY, USA.

Harald Hampel (H)

AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.

Nicole A Kochan (NA)

Center for Healthy Brain Ageing and Dementia Centre for Research Collaboration, University of New South Wales, Sydney, Australia; Neuropsychiatric Institute, Prince of Wales Hospital, Randwick, Australia.

Simone Lista (S)

AXA Research Fund & Sorbonne University Chair, Paris, France; Sorbonne University, GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Paris, France; Brain & Spine Institute (ICM), INSERM U 1127, CNRS UMR 7225, Paris, France; Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.

Tobias Luck (T)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Faculty of Medicine, University of Leipzig, Leipzig, Germany; Social Psychiatry, Department of Economic and Social Sciences, University of Applied Sciences Nordhausen, Nordhausen, Germany.

Paul Maruff (P)

The Florey Institutes of Neurosciences and Mental Health, Melbourne, Australia; Cogstate Ltd., Melbourne, Australia.

José Luis Molinuevo (JL)

Neurology Department, Hospital Clínic i Universitari-IDIBAPS and BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.

Johannes Kornhuber (J)

Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany.

Barry Reisberg (B)

New York University Alzheimer's Disease Center, NYU Langone Medical Center, New York, NY, USA.

Steffi G Riedel-Heller (SG)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Faculty of Medicine, University of Leipzig, Leipzig, Germany.

Shannon L Risacher (SL)

Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, IN, USA; Indiana Alzheimer Disease Center, Indiana University School of Medicine Indianapolis, IN, USA.

Susanne Roehr (S)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Faculty of Medicine, University of Leipzig, Leipzig, Germany; LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Perminder S Sachdev (PS)

Center for Healthy Brain Ageing and Dementia Centre for Research Collaboration, University of New South Wales, Sydney, Australia; Neuropsychiatric Institute, Prince of Wales Hospital, Randwick, Australia.

Nikolaos Scarmeas (N)

National and Kapodistrian University of Athens, Athens, Greece; Department of Neurology, Columbia University Medical Center, New York, NY, USA.

Philip Scheltens (P)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Melanie B Shulman (MB)

New York University Alzheimer's Disease Center, NYU Langone Medical Center, New York, NY, USA.

Andrew J Saykin (AJ)

Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine Indianapolis, IN, USA; Indiana Alzheimer Disease Center, Indiana University School of Medicine Indianapolis, IN, USA.

Sander C J Verfaillie (SCJ)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Pieter Jelle Visser (PJ)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands; Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands.

Stephanie J B Vos (SJB)

Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, Maastricht University, Maastricht, the Netherlands.

Michael Wagner (M)

DZNE, German Center for Neurodegenerative Diseases, Germany; Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.

Steffen Wolfsgruber (S)

DZNE, German Center for Neurodegenerative Diseases, Germany; Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.

Frank Jessen (F)

DZNE, German Center for Neurodegenerative Diseases, Germany; Psychiatry Department, University of Cologne, Cologne, Germany.

Wiesje M van der Flier (WM)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands; Department of Epidemiology and Biostatistics, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands. Electronic address: wm.vdflier@vumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Subjective cognitive decline and rates of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Subjective cognitive decline and rates of...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Troubles de la cognition › Dysfonctionnement cognitif › Subjective cognitive decline and rates of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Subjective cognitive decline and rates of...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Subjective cognitive decline and rates of...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Personnalité › Développement de la personnalité › Concept du soi › Auto-évaluation diagnostique › Subjective cognitive decline and rates of...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Évolution de la maladie › Subjective cognitive decline and rates of...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Subjective cognitive decline and rates of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Incidence › Subjective cognitive decline and rates of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Subjective cognitive decline and rates of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Subjective cognitive decline and rates of...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Personnalité › Développement de la personnalité › Concept du soi › Subjective cognitive decline and rates of...